Transplantation of iPSc Restores Cardiac Function by Promoting Angiogenesis and Ameliorating Cardiac Remodeling in a Post-infarcted Swine Model

Cell Biochemistry and Biophysics

Volumn 71, Issue 3, 2015, Pages 1463-1473

  Song, Guixian ^a   Li, Xiaorong ^a   Shen, Yahui ^b   Qian, Lingmei ^a   Kong, Xiangqing ^a   Chen, Minglong ^a   Cao, Kejiang ^a   Zhang, Fengxiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cardiac remodeling; Fibrosis; Induced pluripotent stem cell; Myocardial infarction

Indexed keywords

ANIMALIA; IPS; SUIDAE;

VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; APOPTOSIS; CELL LINE; CELL PROTECTION; CELL SURVIVAL; CONVALESCENCE; CYTOLOGY; DISEASE MODEL; FIBROSIS; GENE EXPRESSION REGULATION; HEART; HEART VENTRICLE REMODELING; HYPERTROPHY; INDUCED PLURIPOTENT STEM CELL; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PIG; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; CYTOPROTECTION; DISEASE MODELS, ANIMAL; FIBROSIS; GENE EXPRESSION REGULATION; HEART; HYPERTROPHY; INDUCED PLURIPOTENT STEM CELLS; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR REMODELING;

EID: 84930092230     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-014-0369-7     Document Type: Article

References (34)

1. Quijada, P., Toko, H., Fischer, K. M., Bailey, B., Reilly, P., Hunt, K. D., et al. (2012). Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells. Circulation Research,111, 77–86.
2. Takemura, G., & Fujiwara, H. (2004). Role of apoptosis in remodeling after myocardial infarction. Pharmacology and Therapeutics,104, 1–16.
3. Pfeffer, M. A., & Braunwald, E. (1990). Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation,81, 1161–1172.
4. Foo, R. S., Mani, K., & Kitsis, R. N. (2005). Death begets failure in the heart. Journal of Clinical Investigation,115, 565–571.
5. Yamanaka, S. (2007). Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell,1, 39–49.
6. Nishikawa, S., Goldstein, R. A., & Nierras, C. R. (2008). The promise of human induced pluripotent stem cells for research and therapy. Nature Reviews Molecular Cell Biology,9, 725–729.
7. Haase, A., Olmer, R., Schwanke, K., Wunderlich, S., Merkert, S., Hess, C., et al. (2009). Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell,5, 434–441.
8. Mauritz, C., Schwanke, K., Reppel, M., Neef, S., Katsirntaki, K., Maier, L. S., et al. (2008). Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation,118, 507–517.
9. Narazaki, G., Uosaki, H., Teranishi, M., Okita, K., Kim, B., Matsuoka, S., et al. (2008). Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation,118, 498–506.
10. Schenke-Layland, K., Rhodes, K. E., Angelis, E., Butylkova, Y., Heydarkhan-Hagvall, S., Gekas, C., et al. (2008). Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells,26, 1537–1546.
11. Olmer, R., Haase, A., Merkert, S., Cui, W., Palecek, J., Ran, C., et al. (2010). Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Research,5, 51–64.
12. Zweigerdt, R., Olmer, R., Singh, H., Haverich, A., & Martin, U. (2011). Scalable expansion of human pluripotent stem cells in suspension culture. Nature Protocols,6, 689–700.
13. Singla, D. K., Long, X., Glass, C., Singla, R. D., & Yan, B. (2011). Induced pluripotent stem (iPS) cells repair and regenerate infarcted myocardium. Molecular Pharmaceutics,8, 1573–1581.
14. Mauritz, C., Martens, A., Rojas, S. V., Schnick, T., Rathert, C., Schecker, N., et al. (2011). Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. European Heart Journal,32, 2634–2641.
15. Nelson, T. J., Martinez-Fernandez, A., Yamada, S., Perez-Terzic, C., Ikeda, Y., & Terzic, A. (2009). Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation,120, 408–416.
16. Wu, Z., Chen, J., Ren, J., Bao, L., Liao, J., Cui, C., et al. (2009). Generation of pig induced pluripotent stem cells with a drug-inducible system. Journal of Molecular Cell Biology,1, 46–54.
17. Yang, Y. J., Qian, H. Y., Huang, J., Li, J. J., Gao, R. L., Dou, K. F., et al. (2009). Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arteriosclerosis, Thrombosis, and Vascular Biology,29, 2076–2082.
18. Li, C., Tang, L., Yang, Z., & Cao, K. (2011). Integration of dual source computed tomography with magnetic navigation system for percutaneous coronary intervention: a feasibility study. Catheterization and Cardiovascular Interventions,78, 1108–1115.
19. Zhang, S., Ge, J., Zhao, L., Qian, J., Huang, Z., Shen, L., et al. (2007). Host vascular niche contributes to myocardial repair induced by intracoronary transplantation of bone marrow CD34+ progenitor cells in infarcted swine heart. Stem Cells,25, 1195–1203.
20. Zhang, Z., Li, S., Cui, M., Gao, X., Sun, D., Qin, X., et al. (2013). Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3 K/Akt and MEK/ERK pathways. Basic Research in Cardiology,108, 333.
21. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science,318, 1917–1920.
22. Menasche, P. (2004). Cellular transplantation: hurdles remaining before widespread clinical use. Current Opinion in Cardiology,19, 154–161.
23. Amado, L. C., Saliaris, A. P., Schuleri, K. H., St John, M., Xie, J. S., Cattaneo, S., et al. (2005). Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proceedings of the National Academy of Sciences of the USA,102, 11474–11479.
24. Yan, B., Abdelli, L. S., & Singla, D. K. (2011). Transplanted induced pluripotent stem cells improve cardiac function and induce neovascularization in the infarcted hearts of db/db mice. Molecular Pharmaceutics,8, 1602–1610.
25. Bolognese, L., Neskovic, A. N., Parodi, G., Cerisano, G., Buonamici, P., Santoro, G. M., et al. (2002). Left ventricular remodeling after primary coronary angioplasty: Patterns of left ventricular dilation and long-term prognostic implications. Circulation,106, 2351–2357.
26. Hu, Q., Wang, X., Lee, J., Mansoor, A., Liu, J., Zeng, L., et al. (2006). Profound bioenergetic abnormalities in peri-infarct myocardial regions. American Journal of Physiology Heart and Circulatory Physiology,291, 648–657.
27. Kumar, D., & Jugdutt, B. I. (2003). Apoptosis and oxidants in the heart. Journal of Laboratory and Clinical Medicine,142, 288–297.
28. Kumar, D., Lou, H., & Singal, P. K. (2002). Oxidative stress and apoptosis in heart dysfunction. Herz,27, 662–668.
29. Jugdutt, B. I. (2003). Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways. Current Drug Targets: Cardiovascular and Haematological Disorders,3, 1–30.
30. Jugdutt, B. I. (2003). Ventricular remodeling after infarction and the extracellular collagen matrix: When is enough enough. Circulation,108, 1395–1403.
31. Jugdutt, B. I., Menon, V., Kumar, D., & Idikio, H. (2002). Vascular remodeling during healing after myocardial infarction in the dog model: Effects of reperfusion, amlodipine and enalapril. Journal of the American College of Cardiology,39, 1538–1545.
32. Fatma, S., Selby, D. E., Singla, R. D., & Singla, D. K. (2010). Factors Released from Embryonic Stem Cells Stimulate c-kit-FLK-1(+ve) Progenitor Cells and Enhance Neovascularization. Antioxidants and Redox Signaling,13, 1857–1865.
33. Singla, D. K., Lyons, G. E., & Kamp, T. J. (2007). Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. American Journal of Physiology Heart and Circulatory Physiology,293, 1308–1314.
34. Xiong, Q., Ye, L., Zhang, P., Lepley, M., Swingen, C., Zhang, L., et al. (2012). Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells. Circulation Research,111, 455–468.